SG Americas Securities LLC Reduces Stock Position in Encompass Health Co. (NYSE:EHC)

SG Americas Securities LLC trimmed its holdings in shares of Encompass Health Co. (NYSE:EHC) by 70.7% in the fourth quarter, Holdings Channel reports. The institutional investor owned 2,997 shares of the company’s stock after selling 7,220 shares during the period. SG Americas Securities LLC’s holdings in Encompass Health were worth $277,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in EHC. CIBC Asset Management Inc lifted its position in Encompass Health by 3.5% in the third quarter. CIBC Asset Management Inc now owns 2,957 shares of the company’s stock valued at $286,000 after acquiring an additional 100 shares during the last quarter. Miracle Mile Advisors LLC lifted its holdings in shares of Encompass Health by 3.0% in the 4th quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company’s stock valued at $354,000 after purchasing an additional 112 shares during the last quarter. MassMutual Private Wealth & Trust FSB boosted its position in shares of Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after purchasing an additional 137 shares during the period. V Square Quantitative Management LLC grew its stake in Encompass Health by 53.0% during the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after buying an additional 140 shares during the last quarter. Finally, Verdence Capital Advisors LLC lifted its stake in Encompass Health by 4.6% in the third quarter. Verdence Capital Advisors LLC now owns 3,670 shares of the company’s stock valued at $355,000 after buying an additional 160 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Price Performance

Shares of NYSE:EHC opened at $102.18 on Thursday. Encompass Health Co. has a 52 week low of $71.79 and a 52 week high of $104.55. The company has a 50-day moving average price of $96.43 and a 200 day moving average price of $95.08. The company has a market cap of $10.29 billion, a P/E ratio of 24.68, a PEG ratio of 1.18 and a beta of 0.90. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the stock. KeyCorp raised their target price on shares of Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Royal Bank of Canada raised their price objective on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Barclays upped their target price on shares of Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Finally, Truist Financial restated a “buy” rating and issued a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Nine equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, Encompass Health presently has an average rating of “Buy” and an average price target of $107.11.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.